Koronis Pharmaceuticals

Koronis Pharmaceuticals is a Seattle area biotechnology company founded in 1998.

Koronis is dedicated to the development of antiviral therapeutics based on a novel mechanism, Viral Decay Acceleration (VDA).

The Company's lead product candidate is KP-1461 for the treatment of human immunodeficiency virus (HIV) infection.

The company also has products in development for the treatment of hepatitis C and RSV infection.

This article about a medical, pharmaceutical or biotechnological corporation or company is a stub.